Wellfully Ltd

Chart & Performance

D1W1MN

P/E

—

P/S

0.98

EPS

—

Div Yield, %

—

Shrs. gr., 5y

—

Rev. gr., 5y

Revenues

-42.00%

Net income

-6m

L-21.24%

CFO

-2m

L-70.38%

Profile

Wellfully Limited, together with its subsidiaries, focuses on the development and commercialization of Dermaportation and ETP transdermal drug delivery technologies. It operates in two segments, Dermaportation Drug Delivery Technology and Devices. The company is also involved in the industrialization and supply-chain support for its existing product ranges; and sale and marketing of its own brands REDUIT and SWISSWELL, as well as third-party collaborations. It serves the pharmaceutical, cosmetic and skincare, and consumer healthcare sectors. The company was formerly known as OBJ Limited and changed its name to Wellfully Limited in September 2020. Wellfully Limited was incorporated in 1992 and is based in Leederville, Australia.

URL

https://www.obj.com.au/

IPO date

May 29, 2000

Employees

Domiciled in

Incorporated in

Valuation

Order:

Title AUD in thousands, except ratios and share amounts	FY	FY	FY	FY	FY	FY	FY	FY
Title AUD in thousands, except ratios and share amounts	2023‑06	2022‑06	2021‑06	2020‑06	2019‑06	2018‑06	2017‑06	2016‑06
Income
Revenues	1,508 -42.00%
Cost of revenue	5,163
Unusual Expense (Income)
NOPBT	(3,656)
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT	(3,656)
Net income	(6,355) -21.24%
Dividends
Dividend yield
Proceeds from repurchase of equity	3,152
BB yield	-283.21%
Debt
Debt current	224
Long-term debt	221
Deferred revenue
Other long-term liabilities
Net debt	175
Cash flow
Cash from operating activities	(2,443)
CAPEX	(107)
Cash from investing activities	(107)
Cash from financing activities	2,991
FCF	(1,628)
Balance
Cash	270
Long term investments
Excess cash	194
Stockholders' equity	(1,710)
Invested Capital	312
ROIC
ROCE	261.40%
EV
Common stock shares outstanding	371,021
Price	0.00 -94.23%
Market cap	1,113 -91.04%
EV	1,288
EBITDA	(3,542)
EV/EBITDA
Interest
Interest/NOPBT